Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
23,569.60
(
0.13%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
100.84
(
-5.82%
)
Bitcoin
69,834.71
(
1.42%
)
News Focus
News Focus
Post# of 820676
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: meirluc post# 798728

Thursday, 11/20/2025 12:15:47 PM

Thursday, November 20, 2025 12:15:47 PM

Post# of 820676

If the company is aware that the MHRA is substantially delaying its decision, wouldn't that
constitute "Material information" that should be divulged to the shareholders? The fact that
it has not been PRd, is also informative.


Wasn't the 2015 mess that resulted in at best a 5+ year delay and at worse a need for another trial more material? Was that disclosed? Has NWBO ever admitted the results of the IA or the reason for the FDA hold that were the core of that?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News